A systematic review published in Drugs & Aging examined the relationship between testosterone levels and prostate cancer development, as well as the potential risks associated with testosterone replacement therapy (TRT) in aging men. The review found that men with low testosterone levels often develop more malignant and treatment-resistant prostate cancers.
